Tag: Pharmaceutical Industry

Bayer
Healthcare
Germany

Valuation Analysis: Bayer AG

Bayer shows operational progress in the second quarter of 2026. Crop Science and new pharmaceutical products are strengthening the recovery,
Active icon
Continue Umbrella
Bayer
Healthcare
Germany

Stock: Bayer AG

Bayer is operationally improving its earnings position. However, high debt, weak cash flow, and legal risks are slowing the stock's
Active icon
Continue Umbrella
Johnson & Johnson
Healthcare
USA

Valuation Analysis: Johnson & Johnson

Johnson & Johnson is one of the world's leading healthcare companies. The company benefits from a strong position in pharmaceuticals
Active icon
Continue Umbrella
Johnson & Johnson
Healthcare
USA

Stock: Johnson & Johnson

Thanks to a strong pipeline, robust cash flows and a defensive business model, Johnson & Johnson remains a high-quality healthcare
Active icon
Continue Umbrella
Company Update

RED HOT CHILI MUMAK of the Week: Johnson & Johnson – Technical Chart Picture Brightens Significantly

Following strong quarterly figures, a raised annual guidance, and a further improvement in the chart setup, Johnson & Johnson receives
Continue Umbrella